Merus N.V. Common Shares (MRUS) Stock Price, Quote & AI Analysis
Live MRUS stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Merus N.V. Common Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for Merus N.V. Common Shares (NASDAQ: MRUS), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Merus N.V. Common Shares's fundamentals reflect its scale, profitability, and position within the global PHARMACEUTICAL PREPARATIONS sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Merus N.V. Common Shares Overview
Company information
Company Overview
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Merus N.V. Common Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...